Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank57
3Y CAGR+11.2%
5Y CAGR+128.8%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+11.2%/yr
vs -70.4%/yr prior
5Y CAGR
+128.8%/yr
Recent deceleration
Acceleration
+81.6pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
62.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$7.84M-26.7%
2024$10.70M-14.3%
2023$12.48M+119.1%
2022$5.69M+3011.5%
2021$183000.00+46.4%
2020$125000.00-74.6%
2019$492000.00-99.9%
2018$738.28M-